Position in RGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,512,725
+$7,699,381 QoQ
Shares Held
1,378,358
+31.1% QoQ
Ownership
2.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 163 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. RGNX ranks #30 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in RGNX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,512,725 | 1,378,358 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,813,344 | 1,051,712 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $19,612,249 | 1,361,962 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $12,445,169 | 1,289,655 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $7,636,906 | 930,196 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $4,437,252 | 620,595 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $204,333 | 26,434 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $380,335 | 36,257 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $238,434 | 20,379 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $395,832 | 22,052 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $363,420 | 22,079 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $490,874 | 24,556 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,575,240 | 83,302 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,418,592 | 238,915 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,114,310 | 193,504 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,533,705 | 143,065 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,343,896 | 40,491 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $299,690 | 8,786 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $249,842 | 5,508 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $407,130 | 14,794 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $349,185 | 9,481 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $288,894 | 8,922 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||